Cerebral to pause controlled substance prescriptions for new patients
Amid growing controversy over Cerebral's prescribing practices, the digital mental health company will pause prescriptions of controlled substances like Adderall and Ritalin for new patients.
The suspension will begin Monday, May 9, though existing patients can continue to receive their prescribed medications.
Read more...